1. Home
  2. BLTE vs SPT Comparison

BLTE vs SPT Comparison

Compare BLTE & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • SPT
  • Stock Information
  • Founded
  • BLTE 2018
  • SPT 2010
  • Country
  • BLTE United States
  • SPT United States
  • Employees
  • BLTE N/A
  • SPT N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • SPT Computer Software: Prepackaged Software
  • Sector
  • BLTE Health Care
  • SPT Technology
  • Exchange
  • BLTE Nasdaq
  • SPT Nasdaq
  • Market Cap
  • BLTE 1.7B
  • SPT 1.9B
  • IPO Year
  • BLTE 2022
  • SPT 2019
  • Fundamental
  • Price
  • BLTE $57.37
  • SPT $28.41
  • Analyst Decision
  • BLTE Strong Buy
  • SPT Buy
  • Analyst Count
  • BLTE 4
  • SPT 14
  • Target Price
  • BLTE $96.33
  • SPT $40.64
  • AVG Volume (30 Days)
  • BLTE 27.8K
  • SPT 561.3K
  • Earning Date
  • BLTE 03-10-2025
  • SPT 02-25-2025
  • Dividend Yield
  • BLTE N/A
  • SPT N/A
  • EPS Growth
  • BLTE N/A
  • SPT N/A
  • EPS
  • BLTE N/A
  • SPT N/A
  • Revenue
  • BLTE N/A
  • SPT $392,402,000.00
  • Revenue This Year
  • BLTE N/A
  • SPT $22.78
  • Revenue Next Year
  • BLTE N/A
  • SPT $14.52
  • P/E Ratio
  • BLTE N/A
  • SPT N/A
  • Revenue Growth
  • BLTE N/A
  • SPT 26.70
  • 52 Week Low
  • BLTE $31.01
  • SPT $25.05
  • 52 Week High
  • BLTE $86.53
  • SPT $65.53
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 48.86
  • SPT 30.24
  • Support Level
  • BLTE $55.90
  • SPT $31.27
  • Resistance Level
  • BLTE $58.54
  • SPT $32.05
  • Average True Range (ATR)
  • BLTE 2.70
  • SPT 1.51
  • MACD
  • BLTE 0.24
  • SPT -0.53
  • Stochastic Oscillator
  • BLTE 52.14
  • SPT 4.02

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. The firm generates majority revenue from software subscriptions.

Share on Social Networks: